Synopsis : Indian benchmark indices recovered from opening losses on Tuesday, with the Sensex and Nifty trimming declines as strong buying in pharmaceutical stocks offset weakness in IT and metal counters.
While frontline indices remained largely flat, broader markets outperformed, and investor attention shifted to ongoing IPO activity, including the final subscription day for Turtlemint Fintech Solutions and the launch of two new public issues.
Sensex and Nifty Erase Most Opening Losses
The Indian stock market showed resilience during Tuesday's trading session as benchmark indices bounced back from early weakness. Support from pharmaceutical heavyweights helped the markets recover, even as select sectors continued to face selling pressure.
As of 11:00 AM, the NSE Nifty50 was trading at 24,093.60, down just 9.3 points or 0.04 percent. Meanwhile, the BSE Sensex stood at 77,075.68, lower by only 18.39 points or 0.02 percent after recovering significantly from intraday lows.
The recovery highlighted investors' willingness to accumulate defensive stocks despite cautious sentiment in certain sectors.
Pharma Giants Support the Market
The pharmaceutical sector emerged as the market's biggest strength during the session.
Leading the recovery were:
- Dr. Reddy’s Laboratories
- Sun Pharmaceutical Industries
- Cipla
Strong buying in these healthcare majors helped offset losses in technology and metal stocks, preventing a deeper decline in benchmark indices.
The Nifty Pharma and Nifty Healthcare indices outperformed the broader market, attracting investors seeking defensive opportunities amid mixed market conditions.
IT and Metal Stocks Under Pressure
While pharma stocks advanced, the Nifty IT and Nifty Metal indices witnessed the sharpest declines among sectoral benchmarks.
Technology stocks faced profit-booking pressure after recent gains, while metal counters remained weak amid concerns over global demand and commodity price fluctuations.
Despite these headwinds, the broader market sentiment remained constructive.
Broader Markets Outperform Benchmarks
Mid-cap and small-cap stocks continued to attract investor interest, outperforming the benchmark indices.
- Nifty MidCap Index gained 0.15 percent
- Nifty SmallCap Index rose 0.21 percent
Among standout performers in the broader market space, Prestige Estates and Cohance Life Sciences emerged as top gainers, reflecting selective buying across real estate and healthcare segments.
IPO Market Remains Active
The primary market continued to generate strong investor interest with multiple public offerings in focus.
Turtlemint Fintech Solutions IPO
The ₹882.67 crore IPO of Turtlemint Fintech Solutions entered its final day of subscription. The book-built issue comprises a combination of a fresh issue and an offer for sale.
New IPO Launches
Two fresh public issues opened for subscription on Tuesday:
- Advit Jewels IPO – ₹165.16 crore
- Waterways Leisure Tourism IPO – ₹585 crore
Both offerings are book-built issues and are expected to attract attention from investors looking for opportunities in the primary market.
Market Outlook
The recovery from opening losses suggests that investors remain optimistic despite sector-specific weakness. Strong participation in pharma and healthcare stocks, coupled with steady performance in the broader market, indicates underlying strength in market sentiment.
Going forward, investors will closely monitor corporate earnings, foreign fund flows, global market developments, and IPO subscription trends for further direction. If defensive sectors continue to attract buying interest, markets may remain stable despite volatility in technology and cyclical stocks.
Disclaimer : This article is for informational purposes only and should not be considered financial or investment advice. Investors should consult a qualified financial advisor before making any investment decisions.
.jpg)
